BridgeMD
New treatment option for IV Infiltration
Official title Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
ClinicalTrials.gov ID: NCT07009405
What this study is testing
- What it's testing
- This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- Scheduled to receive an infusion therapy of at least 30 minutes in length
- Region of intact skin proximal to the infusion catheter insertion site that is appropriate in size for application of the study device
- Signed informed consent
- Available for 15 minutes of post-measurement monitoring following removal of the study device
You likely can't join if
- Patient is under 12 years of age
- Patient-reported history of serious adverse skin reactions to silicone-based adhesives or Tegaderm
- Use of the study device would interfere with standard patient care that cannot be delayed, or participation in the study will interfere with, or be...
- Investigator judges that the intravenous
The study team makes the final eligibility decision.
Where it's taking place
- Skokie, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Skokie, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.